Skip to main content

Table 4 Comparison of diagnostic efficacy of sacroiliac joint sacral and iliac relaxation time values

From: Monitoring the efficacy of tumor necrosis factor alpha antagonists in the treatment of Ankylosing spondylarthritis: a pilot study based on MR relaxometry technique

  

AUC

sensitivity

specificity

P

Control group-case group

T1-mapping(ms) sacral

0.912

0.788

0.933

 < 0.001

T1-mapping(ms) iliac

0.935

0.869

0.933

 < 0.001

T2*-mapping(ms) sacral

0.798

0.576

0.933

 < 0.001

T2*-mapping(ms) iliac

0.802

0.556

0.933

 < 0.001

Control group-inactive group

T1-mapping(ms) sacral

0.840

0.900

0.733

0.001

T1-mapping(ms) iliac

0.920

0.900

0.867

 < 0.001

T2*-mapping(ms) sacral

0.718

0.650

0.800

0.029

T2*-mapping(ms) iliac

0.765

0.800

0.667

0.008

Control group-active group

T1-mapping(ms) sacral

0.930

0.848

0.933

 < 0.001

T1-mapping(ms) iliac

0.939

0.899

0.933

 < 0.001

T2*-mapping(ms) sacral

0.819

0.633

0.933

 < 0.001

T2*-mapping(ms) iliac

0.811

0.582

0.933

 < 0.001

Inactive group-active group

T1-mapping(ms) sacral

0.795

0.671

0.900

 < 0.001

T1-mapping(ms) iliac

0.770

0.709

0.800

 < 0.001

T2*-mapping(ms) sacral

0.674

0.595

0.750

0.017

T2*-mapping(ms) iliac

0.643

0.430

0.950

0.048